Free Trial

Abeona Therapeutics (ABEO) News Today

Abeona Therapeutics logo
$6.42 -0.16 (-2.43%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$6.46 +0.04 (+0.55%)
As of 05/23/2025 06:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Why is Abeona Therapeutics Down Today?

Abeona Therapeutics Inc (NASDAQ:ABEO) saw multiple analyst estimate revisions this week, driving positive momentum in its shares.

  • Zacks Small Cap raised its FY2025 EPS forecast from ($0.74) to ($0.64)
  • Cantor Fitzgerald lifted its FY2025 EPS view from ($1.17) to ($0.96)
  • Analysts set a consensus price target of $18.50, suggesting upside potential
  • HC Wainwright maintains a “Buy” rating with a $20.00 target, reflecting confidence despite mixed estimates
  • HC Wainwright lowered its Q2 2025 EPS estimate to ($0.39) from ($0.37)

Overall, improved full‐year earnings forecasts and strong price targets have lifted investor sentiment, and ABEO shares have increased on the session.

Posted 1+ days agoAI Generated. May Contain Errors.

ABEO Latest News

Abeona Therapeutics Inc stock logo
FY2025 Earnings Forecast for ABEO Issued By Zacks Small Cap
Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) - Equities researchers at Zacks Small Cap raised their FY2025 earnings estimates for Abeona Therapeutics in a report issued on Monday, May 19th. Zacks Small Cap analyst D. Bautz now forecasts that the biopharmaceutical company will earn ($0.64)
Abeona Therapeutics Inc stock logo
FY2025 EPS Estimates for ABEO Lifted by Cantor Fitzgerald
Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) - Analysts at Cantor Fitzgerald upped their FY2025 earnings per share estimates for shares of Abeona Therapeutics in a research report issued on Monday, May 19th. Cantor Fitzgerald analyst K. Kluska now expects that the biopharmaceutical company
Abeona Therapeutics Inc stock logo
HC Wainwright Issues Pessimistic Outlook for ABEO Earnings
Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) - Stock analysts at HC Wainwright reduced their Q2 2025 earnings per share estimates for Abeona Therapeutics in a report issued on Monday, May 19th. HC Wainwright analyst R. Selvaraju now expects that the biopharmaceutical company will earn ($0.
FY2025 Earnings Estimate for ABEO Issued By Zacks Small Cap
Equities Analysts Offer Predictions for ABEO FY2025 Earnings
HC Wainwright Has Negative Estimate for ABEO Q2 Earnings
Abeona Therapeutics Inc stock logo
Abeona Therapeutics Inc (NASDAQ:ABEO) is Western Standard LLC's 3rd Largest Position
Western Standard LLC increased its position in shares of Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) by 22.8% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 2,084,418 shares of the biopharmaceutical company's stock after purchasing an
Abeona Therapeutics Inc stock logo
OMERS ADMINISTRATION Corp Takes $362,000 Position in Abeona Therapeutics Inc (NASDAQ:ABEO)
OMERS ADMINISTRATION Corp bought a new stake in Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 65,045 shares of the biopharmaceutical company's stock, valued at approxi
Abeona Therapeutics Inc stock logo
Abeona Therapeutics Inc (NASDAQ:ABEO) Receives Consensus Recommendation of "Buy" from Brokerages
Abeona Therapeutics Inc (NASDAQ:ABEO - Get Free Report) has been assigned a consensus recommendation of "Buy" from the four ratings firms that are presently covering the stock, MarketBeat Ratings reports. Four investment analysts have rated the stock with a buy recommendation. The average 12-month
Abeona Therapeutics Inc stock logo
Abeona Therapeutics (ABEO) Expected to Announce Earnings on Wednesday
Abeona Therapeutics (NASDAQ:ABEO) will be releasing its Q1 2025 earnings before the market opens on Wednesday, May 21. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-21-abeona-therapeutics-inc-stock/)
Abeona Therapeutics Inc stock logo
Schonfeld Strategic Advisors LLC Makes New Investment in Abeona Therapeutics Inc (NASDAQ:ABEO)
Schonfeld Strategic Advisors LLC acquired a new position in shares of Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 61,266 shares of the biopharma
Abeona Therapeutics Inc stock logo
Abeona Therapeutics Sees Unusually High Options Volume (NASDAQ:ABEO)
Abeona Therapeutics Inc (NASDAQ:ABEO - Get Free Report) was the recipient of some unusual options trading on Monday. Investors acquired 5,499 call options on the stock. This is an increase of 657% compared to the average daily volume of 726 call options.
Abeona Therapeutics Inc stock logo
Renaissance Technologies LLC Has $497,000 Holdings in Abeona Therapeutics Inc (NASDAQ:ABEO)
Renaissance Technologies LLC decreased its position in shares of Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) by 33.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 89,237 shares of th
Abeona Therapeutics Inc stock logo
ABEO FY2025 EPS Forecast Boosted by Cantor Fitzgerald
Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) - Equities researchers at Cantor Fitzgerald lifted their FY2025 earnings estimates for Abeona Therapeutics in a report released on Wednesday, April 30th. Cantor Fitzgerald analyst K. Kluska now expects that the biopharmaceutical company will pos
Abeona Therapeutics Inc stock logo
Q3 EPS Estimate for Abeona Therapeutics Boosted by Analyst
Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) - Research analysts at Zacks Small Cap raised their Q3 2025 earnings per share estimates for Abeona Therapeutics in a research report issued on Wednesday, April 30th. Zacks Small Cap analyst D. Bautz now anticipates that the biopharmaceutical co
Abeona Therapeutics Inc stock logo
Q2 EPS Forecast for Abeona Therapeutics Decreased by Analyst
Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) - Research analysts at HC Wainwright lowered their Q2 2025 earnings per share (EPS) estimates for Abeona Therapeutics in a research report issued to clients and investors on Wednesday, April 30th. HC Wainwright analyst R. Selvaraju now anticipat
Abeona Therapeutics Inc stock logo
Abeona Therapeutics Inc (NASDAQ:ABEO) Shares Acquired by 683 Capital Management LLC
683 Capital Management LLC boosted its stake in shares of Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) by 17.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 791,845 shares of the biopharmaceuti
Abeona Therapeutics Inc stock logo
Abeona Therapeutics Inc (NASDAQ:ABEO) Short Interest Update
Abeona Therapeutics Inc (NASDAQ:ABEO - Get Free Report) was the target of a large growth in short interest in April. As of April 15th, there was short interest totalling 2,760,000 shares, a growth of 24.9% from the March 31st total of 2,210,000 shares. Based on an average daily trading volume, of 556,500 shares, the short-interest ratio is presently 5.0 days. Currently, 6.4% of the shares of the company are sold short.
Abeona Therapeutics Inc stock logo
Abeona Therapeutics (NASDAQ:ABEO) Price Target Raised to $20.00 at HC Wainwright
HC Wainwright lifted their target price on shares of Abeona Therapeutics from $15.00 to $20.00 and gave the stock a "buy" rating in a research note on Wednesday.
Abeona Therapeutics Inc stock logo
Adage Capital Partners GP L.L.C. Has $21.74 Million Stock Position in Abeona Therapeutics Inc (NASDAQ:ABEO)
Adage Capital Partners GP L.L.C. raised its position in Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) by 20.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,902,360 shares of
Abeona Therapeutics Inc stock logo
Abeona Therapeutics (NASDAQ:ABEO) Stock Price Passes Above 50-Day Moving Average - Time to Sell?
Abeona Therapeutics (NASDAQ:ABEO) Share Price Crosses Above Fifty Day Moving Average - Time to Sell?
Abeona Therapeutics Inc stock logo
Walleye Capital LLC Reduces Stock Holdings in Abeona Therapeutics Inc (NASDAQ:ABEO)
Walleye Capital LLC reduced its stake in shares of Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) by 31.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 586,250 shares of the biopharmaceutical company's stock after
Abeona Therapeutics Inc stock logo
Wellington Management Group LLP Acquires Shares of 93,289 Abeona Therapeutics Inc (NASDAQ:ABEO)
Wellington Management Group LLP acquired a new stake in Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 93,289 shares of the biopharmaceutical company's stock, valued
Abeona Therapeutics Inc stock logo
Trexquant Investment LP Invests $382,000 in Abeona Therapeutics Inc (NASDAQ:ABEO)
Trexquant Investment LP acquired a new position in shares of Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 68,516 shares of the biopharmaceutical company's stock, valued at approximately $38
Get Abeona Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABEO and its competitors with MarketBeat's FREE daily newsletter.

ABEO Media Mentions By Week

ABEO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ABEO
News Sentiment

0.51

0.75

Average
Medical
News Sentiment

ABEO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ABEO Articles
This Week

20

3

ABEO Articles
Average Week

Get Abeona Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABEO and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:ABEO) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners